Epalinges, Switzerland

Apoxis S.a.


USPTO Granted Patents = 7

% Expired Patents = 57.1


Forward Citations = 157

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Jurg Tschopp (4 out of 10 patents)

silverMedal Pascal Schneider (3 out of 18 patents)

bronzeMedal Catherine A Hession (3 out of 19 patents)

4.  Christine Ambrose (2 out of 17 patents)

5.  Jeffrey Thompson (2 out of 16 patents)

6.  Paul David Rennert (1 out of 33 patents)

7.  Fabienne MacKay (1 out of 8 patents)

8.  Teresa G Cachero (1 out of 7 patents)

9.  Olivier Gaide (1 out of 3 patents)

10.  Jeffrey L Browning (1 out of 43 patents)

11.  Jürg Tschopp (1 out of 2 patents)

12.  Browning Jeffrey (1 out of 1 patent)

13.  Ambrose Christine (1 out of 1 patent)

14.  MacKay Fabienne (1 out of 1 patent)

15.  Tschopp Jurg (1 out of 1 patent)


7 patents:

Apoxis S.a. is a pharmaceutical company specializing in the development of innovative cancer therapies. With a focus on precision medicine, Apoxis aims to provide personalized treatment options for patients with various types of cancers. Through cutting-edge research and development, Apoxis is committed to improving outcomes and quality of life for cancer patients worldwide.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

7 Patents

#4 in Epalinges

#1,339 in Switzerland

Epalinges, CH
Epalinges, Switzerland
Forward Citations = 157

17 inventors:

Please report any incorrect information to [email protected]
Loading…